Duration of antiretroviral regimens in treatment-experienced patients in clinical practice

被引：0
|
作者：
Vicente Escudero Vilaplana
Sergio Plata Paniagua
Nicolas Trovato Lopez
Isabel Castillo Romera
Arantza Ais Larisgoitia
Jose Maria Bellon Cano
Maria Sanjurjo Saez
机构：
[1] Hospital General Universitario Gregorio Marañon,
来源：
Retrovirology | / 7卷
关键词：
Control Variable; Viral Load; Primary Endpoint; Treatment Failure; Efavirenz;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] THE USE OF INTEGRASE INHIBITORS IN TREATMENT-EXPERIENCED PATIENTS
    Gatell, Jose M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 30 - 35
  • [42] TREATMENT PERSISTENCE AMONG TREATMENT-EXPERIENCED PEOPLE WITH HIV (PWH) SWITCHING TO INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)-BASED HIV ANTIRETROVIRAL REGIMENS
    Chuo, C. Y.
    Christoph, M. J.
    Zachry, W.
    de Boer, M.
    Chen, M.
    Trom, C.
    VALUE IN HEALTH, 2024, 27 (06) : S318 - S318
  • [43] Susceptibility of HIV-1 to Tipranavir and Other Antiretroviral Agents in Treatment-Experienced Patients: The UTILIZE Study
    Baxter, John D.
    Bhatti, Laveeza
    Coakley, Eoin
    Bartczak, Jennifer
    McDonough, Marita
    Vinisko, Richard
    Piliero, Peter J.
    CURRENT HIV RESEARCH, 2010, 8 (04) : 347 - 354
  • [44] Once-daily antiretroviral therapy among treatment-experienced Muslim patients fasting for the month of Ramadan
    Yakasai, Ahmed M.
    Muhammad, Hamza
    Babashani, Musa
    Jumare, Jibreel
    Abdulmumini, Murjanatu
    Habib, Abdulrazaq G.
    TROPICAL DOCTOR, 2011, 41 (04) : 233 - 235
  • [45] Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1-Infected Patients in Switzerland
    Elbasha, E. E.
    Szucs, T.
    Chaudhary, M. A.
    Kumar, R. N.
    Roediger, A.
    Cook, J. R.
    Opravil, M.
    HIV CLINICAL TRIALS, 2009, 10 (04): : 233 - 253
  • [46] Virologic and immunologic impact and durability of enfuvirtide-based antiretroviral therapy in HIV-infected treatment-experienced patients in a clinical setting
    Loutfy, M. R.
    Antoniou, T.
    Shen, S.
    Vlaicu, M.
    Halpenny, R.
    Kovacs, C.
    Fletcher, D.
    Raboud, J. M.
    HIV CLINICAL TRIALS, 2007, 8 (01): : 36 - 44
  • [47] Raltegravir Plasma Concentrations in Treatment-Experienced Patients Receiving Salvage Regimens Based on Raltegravir With and Without Maraviroc Coadministration
    Baroncelli, Silvia
    Villani, Paola
    Weimer, Liliana E.
    Ladisa, Nicoletta
    Francisci, Daniela
    Tommasi, Chiara
    Vullo, Vincenzo
    Preziosi, Roberta
    Cicalini, Stefania
    Cusato, Maria
    Galluzzo, Clementina M.
    Floridia, Marco
    Regazzi, Mario
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 838 - 843
  • [48] The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients
    Di Biagio, Antonio
    Ricci, Elena
    Viscoli, Claudio
    Mesini, Alessio
    Menzaghi, Barbara
    Carenzi, Laura
    Orofino, Giancarlo
    Parruti, Giustino
    Martinelli, Canio
    Madeddu, Giordano
    De Socio, Giuseppe V.
    Franzetti, Marco
    Quirino, Tiziana
    Bonfanti, Paolo
    CURRENT HIV RESEARCH, 2013, 11 (03) : 179 - 186
  • [49] Management of chronic hepatitis B in treatment-experienced patients
    Hui, CK
    Zhang, HY
    Lau, GKK
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 601 - +
  • [50] HIV: how to manage heavily treatment-experienced patients
    Spivack, Stephanie
    Pagkalinawan, Stephen
    Samuel, Rafik
    Koren, David E.
    DRUGS IN CONTEXT, 2022, 11
12345